ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AZN Astrazeneca Plc

12,060.00
-44.00 (-0.36%)
Last Updated: 10:09:13
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -44.00 -0.36% 12,060.00 12,060.00 12,062.00 12,068.00 11,990.00 12,020.00 66,245 10:09:13
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.35 187.63B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 12,104p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,704.00p.

Astrazeneca currently has 1,550,189,338 shares in issue. The market capitalisation of Astrazeneca is £187.63 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 31.35.

Astrazeneca Share Discussion Threads

Showing 6151 to 6173 of 6175 messages
Chat Pages: 247  246  245  244  243  242  241  240  239  238  237  236  Older
DateSubjectAuthorDiscuss
28/6/2024
11:46
Switched to RNK [better change to capital gains] 4 brokers issued strong BUY
blackhorse23
12/6/2024
10:22
Money moved to APH [Alliance Pharma]
blackhorse23
11/6/2024
12:34
aph quality poor, nowhere near the same outfit as eg AZN
c3479z
06/6/2024
16:19
They raised APH ( alliance Pharma ) to BUY as well
blackhorse23
05/6/2024
10:12
HSBC raises AstraZeneca price target to 14,070 (12,950) pence - 'buy'
philanderer
30/5/2024
10:27
Goldman starts AstraZeneca with 'buy' - price target 15,200 pence
philanderer
23/5/2024
20:22
Meanwhile Nvidia rises as much in a day as Astras market value , nuts .
holts
22/5/2024
11:27
Stifel raises AstraZeneca price target to 13,700 (12,800) pence - 'buy'
philanderer
13/5/2024
10:11
Money moved to APH ( alliance Pharma )
blackhorse23
11/5/2024
22:31
Getting close to time to sell, and buy back cheaper?
1knocker
11/5/2024
21:56
RSI looking grossly over bought...
diku
08/5/2024
22:17
BBC News - AstraZeneca to withdraw Covid vaccinehttps://www.bbc.co.uk/news/health-68977026
kasg
08/5/2024
20:35
Most big pharma have GLP-1 agonists on trial. Let's hope AZN's has the least side effects!
gregb
08/5/2024
17:23
Astra have a little obesity pill that they'll be putting out the phase one results for soon. And at least one other obesity project. I think the plan is to combine the pill with other drugs to treat medical conditions and also sell a cheap version for cosmetic weight loss.
smcni1968
08/5/2024
06:24
Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Berenberg expects Astrazeneca to state a new revenue ambition at its 21 May investor day, highlighting confidence in growth to 2030 from already visible assets. High single-digit growth would equate to a roughly $75.0bn-80.0bn top line and approximately 20% upside to consensus, it noted.

"On our estimates, global large pharma is on track to grow sales at 4% pa for 2026-30 (range -2% to 13%) with an average 2025 P/E of 16.6x (range 7-42x). High single-digit growth would put Astrazeneca at the top end of the non-obesity range and warrant a multiple above 20x, in our view," said Berenberg.

The German bank stated it was raising its price target to reflect "recent, positive pipeline updates", which implies a 2025 price-to-earnings ratio of 19x.

"We reiterate our 'buy' recommendation as positive pipeline momentum through to 2025 has the potential to unlock sales upgrades and share price upside," said Berenberg.

"Astrazeneca offers top-tier sales growth at an attractive valuation, with a P/E of 17.4x 2025E versus an EU sector average of 15.7x and EV/NPV of 1.05x versus an average of 1.01x"

hotfinance14
07/5/2024
13:06
Berenberg raises AstraZeneca price target to 13,000 (12,000) pence - 'buy'
philanderer
03/5/2024
10:53
Money moving to APH AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders-DIVIDEND +5% -PORTFOLIO BROADENED THROUGH ACQUISITION
blackhorse23
25/4/2024
16:10
AstraZeneca overtakes Shell as Britain’s most valuable company
philanderer
25/4/2024
10:03
Quality advice from Deutsche Bank :-)
holts
25/4/2024
09:44
So glad I dipped in at £97.70.7 a few months ago.
Good results from a solid company.

beckers2008
25/4/2024
08:41
Mr buywell, I hope you are fully recovered from your bout of alzheimers and enjoying the set of great results today
harry_david
25/4/2024
08:39
Decent report .
holts
18/4/2024
10:21
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders-DIVIDEND +5% -PORTFOLIO BROADENED THROUGH ACQUISITION
blackhorse23
Chat Pages: 247  246  245  244  243  242  241  240  239  238  237  236  Older

Your Recent History

Delayed Upgrade Clock